SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Zwiener who wrote (743)12/23/1997 9:16:00 PM
From: luis a. garcia  Read Replies (2) of 1115
 
John I thougth BMY and or Yamanouchi can manufacture this drug if they so choose. A contract manufacturer can too I suppose. Someone is been making this for several years and they should have a validated pilot process.. question is, can they make enough or will Yamanouchi have to invest in a new process and validate it and all the permiting and labeling that entails.. and if they do.. this is the time to start that process.. I mean we are late to market and should not waste one more minute than is absolutely necesary.
I can tell you if we assume say a 100 percent growth rate then with
.50 cnts per share gets us 50 dollars.. but nobody pays full valuation
rigth so its good for 25-30 dollars..
luis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext